Skip to Content

Chimeric Therapeutics Ltd Ordinary Shares CHM Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CHM

Valuation
Currency in AUD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics CHM

Company Profile CHM

Business Description

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells.

Contact
62 Lygon Street, Level 3, Carlton South
Melbourne, VIC, 3053, Australia
T +61 398245254
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Jun 30, 2021
Employees